| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8453889 | Lung Cancer | 2018 | 31 Pages |
Abstract
Severe AEs among elderly patients with aNSCLC treated with second-line chemotherapy/targeted therapy were found to be associated with decreased OS and increased healthcare costs. Results suggest a potential link between severe AEs in second-line treated aNSCLC elderly and patient survival and economic burden to the healthcare system.
Keywords
EGFRPPPMDRGPD-L1GLMHMOICD-9ALKSurvivaloverall survivalSecond-line therapyhealth maintenance organizationAdvanced non-small cell lung cancerSEERadverse eventAnaplastic lymphoma kinaseGeneralized linear modelprogrammed death-ligand 1hazard ratioSurveillance, Epidemiology, and End ResultsCostsDiagnosis-related groupEpidermal growth factor receptor
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Hossein Borghaei, Yeun Mi Yim, Annie Guerin, Irina Pivneva, Sherry Shi, Mayank Gandhi, Raluca Ionescu-Ittu,